Innospec Net Income Over Time
| OCT Stock | EUR 72.50 1.00 1.36% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Innospec Performance and Innospec Correlation. Innospec |
Cross Equities Net Income Analysis
Compare Innospec and related stocks such as Abbott Laboratories, DANAHER (DAPSG), and Merck Net Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABL | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 477 M | 2.4 B | 3.7 B | 4.5 B | 7.1 B | 6.9 B | 5.7 B | 13.4 B | 15.4 B | 16.2 B |
| DAP | 2.6 B | 2.6 B | 2.6 B | 2.6 B | 2.6 B | 2.6 B | 2.6 B | 2.5 B | 2.7 B | 3 B | 3.6 B | 6.4 B | 7.2 B | 4.8 B | 3.9 B | 4.5 B | 4.5 B |
| 6MK | 3.9 B | 3.9 B | 3.9 B | 3.9 B | 3.9 B | 3.9 B | 3.9 B | 2.4 B | 6.2 B | 9.8 B | 7.1 B | 13 B | 14.5 B | 365 M | 17.1 B | 19.7 B | 20.7 B |
| AMD | (497 M) | (497 M) | (497 M) | (497 M) | (497 M) | (497 M) | (497 M) | 43 M | 337 M | 341 M | 2.5 B | 3.2 B | 1.3 B | 854 M | 1.6 B | 4.3 B | 4.6 B |
| 4I1 | 7 B | 7 B | 7 B | 7 B | 7 B | 7 B | 7 B | 6 B | 7.9 B | 7.2 B | 8.1 B | 9.1 B | 9 B | 7.8 B | 7.1 B | 11.3 B | 8.9 B |
| W8V | 164.6 B | 164.6 B | 164.6 B | 164.6 B | 164.6 B | 164.6 B | 164.6 B | 172.4 B | 180.1 B | 187.4 B | 192.9 B | 216.6 B | 226.5 B | 231.9 B | 237.8 B | 273.5 B | 221.2 B |
| TOTB | 6.2 B | 6.2 B | 6.2 B | 6.2 B | 6.2 B | 6.2 B | 6.2 B | 8.6 B | 11.4 B | 11.3 B | (7.2 B) | 16 B | 20.5 B | 21.4 B | 15.8 B | 18.1 B | 12.7 B |
| AMG | 7.7 B | 7.7 B | 7.7 B | 7.7 B | 7.7 B | 7.7 B | 7.7 B | 2 B | 8.4 B | 7.8 B | 7.3 B | 5.9 B | 6.6 B | 6.7 B | 4.1 B | 3.7 B | 5 B |
| HBC1 | 16.2 B | 16.2 B | 16.2 B | 16.2 B | 13.7 B | 13.5 B | 2.5 B | 10.8 B | 13.7 B | 7.4 B | 5.2 B | 13.9 B | 15.6 B | 23.5 B | 24 B | 27.6 B | 14.7 B |
| HK2C | 5.8 B | 5.8 B | 5.8 B | 5.8 B | 5.8 B | 5.8 B | 5.8 B | 7.4 B | 9.3 B | 9.4 B | 11.5 B | 12.5 B | 10.1 B | 11.9 B | 13.1 B | 15 B | 11.1 B |
Innospec and related stocks such as Abbott Laboratories, DANAHER (DAPSG), and Merck Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Innospec financial statement analysis. It represents the amount of money remaining after all of Innospec operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Innospec | OCT |
Specialization | Basic Materials, Specialty Chemicals |
| Business Address | 8310 South Valley |
| Exchange | Frankfurt Exchange |
EUR 72.5
Check out Innospec Performance and Innospec Correlation. For more detail on how to invest in Innospec Stock please use our How to Invest in Innospec guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Innospec technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.